Octapharma USA is offering Balfaxar (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex). The new non-activated four factor prothrombin complex concentrate (4F-PCC) ...

PARAMUS, N.J., July 26, 2023 – Octapharma USA today announced that Balfaxar ® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex ®) has received U.S. Food and Drug ...

More than 2.4 million people in the United States use warfarin to keep their blood from clotting after a heart attack, stroke or other serious thromboembolic complication. But using a blood thinner ...

Blood products, such as prothrombin complex concentrate, should be used only when the international normalized ratio (INR) is at least 1.5 and the patient has major bleeding (e.g., intracranial ...

As a result of research undertaken by the University of Sheffield between 1995-2002, a new gold standard treatment for major bleeding when using warfarin has been established. The treatment, using ...

A deficiency of one or more components of the prothrombin complex may complicate many clinical states: cirrhosis; hepatitis; biliary obstruction; malabsorption; childbirth; and the preoperative and ...